The Belfer Center actively collaborates with two key groups of stakeholders in therapeutic oncology research:
- Pharmaceutical and biotechnology companies seeking to bring basic and preclinical scientific breakthroughs to market in the form of new therapeutic products (small molecule drugs, biologics, immunotherapies, etc.)
- Academic physician/scientists conducting basic and translational oncology research and clinical studies, who care for patients with cancer on a daily basis
We bring unique capabilities and value to our collaborations and welcome additional alliances. Please contact us to discuss potential collaborations.